Rabbit Anti-Human VPAC1 Monoclonal Antibody (Clone SP234)
For research use only. Not for use in diagnostics.
| Product No. | Pack Size |
|---|---|
| 07112670001 | 0.1 mL |
| Product No. | Pack Size |
|---|---|
| 07112718001 | 1.0 mL |
To order these products, please contact your Roche order management team.
Vasoactive intestinal peptide (VIP) receptors 1 and 2, termed VPAC1 and VPAC2, are members of the 7 transmembrane G protein-coupled receptor family. Both receptors bind to VIP and pituitary adenylate cyclase-activating polypeptide (PACAP). Interaction of VIP and VPAC1 inhibit megakaryocyte proliferation and induces proplatelet formation. VPAC1 is expressed in subset of mononuclear cells and it is highly expressed in some lung adenocarcinoma.
Figure above:
Human tonsil stained with anti-VPAC1 antibody
Contents
Rabbit monoclonal antibody purified by protein A/G in PBS/1% BSA buffer pH 7.6 with less than 0.1% sodium azide.
IHC Performance
|
Human Tonsil stained with anti-VPAC1 antibody |
Flow Cytometric Analysis
Flow cytometric analysis of rabbit anti-VPAC1 (SP234) antibody in A431 (green) compare to negative control of rabbit IgG (blue)
Product Details:
Technology |
Rabbit Monoclonal |
Clone Name |
SP234 |
Application |
IHC-P, FACS |
Species Reactivity |
|
Tested |
Hu |
Predicted by homology |
Ms, Pg, Rt |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide derived from human VPAC1 protein. |
Cellular Localization |
|
Control Tissue |
Tonsil |
Regulatory Rating |
Research Use Only (RUO) |
Entrez |
7433 |
Storage Requirement |
2-8°C |
Target Molecular Weight |
52 kDa |
Formulation |
Refer to Data Sheet |
Associated Products
Instructions for Use (IFU)
Search now
Online Technical Support
Find help